1. Home
  2. SLN vs EVI Comparison

SLN vs EVI Comparison

Compare SLN & EVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • EVI
  • Stock Information
  • Founded
  • SLN 1994
  • EVI 1959
  • Country
  • SLN United Kingdom
  • EVI United States
  • Employees
  • SLN N/A
  • EVI N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • EVI Other Consumer Services
  • Sector
  • SLN Health Care
  • EVI Consumer Discretionary
  • Exchange
  • SLN Nasdaq
  • EVI Nasdaq
  • Market Cap
  • SLN 281.0M
  • EVI 236.3M
  • IPO Year
  • SLN N/A
  • EVI N/A
  • Fundamental
  • Price
  • SLN $5.92
  • EVI $23.50
  • Analyst Decision
  • SLN Buy
  • EVI Strong Buy
  • Analyst Count
  • SLN 5
  • EVI 1
  • Target Price
  • SLN $32.60
  • EVI $28.00
  • AVG Volume (30 Days)
  • SLN 111.7K
  • EVI 29.8K
  • Earning Date
  • SLN 08-14-2025
  • EVI 05-12-2025
  • Dividend Yield
  • SLN N/A
  • EVI 1.31%
  • EPS Growth
  • SLN N/A
  • EVI 29.85
  • EPS
  • SLN N/A
  • EVI 0.48
  • Revenue
  • SLN $27,701,000.00
  • EVI $370,020,000.00
  • Revenue This Year
  • SLN N/A
  • EVI $25.04
  • Revenue Next Year
  • SLN N/A
  • EVI N/A
  • P/E Ratio
  • SLN N/A
  • EVI $49.13
  • Revenue Growth
  • SLN N/A
  • EVI 3.51
  • 52 Week Low
  • SLN $1.97
  • EVI $14.51
  • 52 Week High
  • SLN $22.47
  • EVI $23.70
  • Technical
  • Relative Strength Index (RSI)
  • SLN 58.35
  • EVI 70.16
  • Support Level
  • SLN $5.33
  • EVI $18.37
  • Resistance Level
  • SLN $6.00
  • EVI $20.50
  • Average True Range (ATR)
  • SLN 0.44
  • EVI 1.16
  • MACD
  • SLN -0.03
  • EVI 0.28
  • Stochastic Oscillator
  • SLN 64.07
  • EVI 85.46

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About EVI EVI Industries Inc.

EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean, and Latin America.

Share on Social Networks: